Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00275210
Status:
COMPLETED
Last Update Posted:
2009-04-20
First Post:
2006-01-03
Brief Title:
MOSAIC - Multicenter International Study of Oxaliplatin 5FU-LV in the Adjuvant Treatment of Colon Cancer
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Multicenter International Study of Oxaliplatin 5FU-LV in the Adjuvant Treatment of Colon Cancer
Status:
COMPLETED
Status Verified Date:
2009-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the FOLFOX regimen versus LV5FU2 in the adjuvant treatment of stage II and III colon cancer
Primary objective Disease Free Survival DFS Secondary objective Overall Survival OS safety including long term toxicity
Primary objective Disease Free Survival DFS Secondary objective Overall Survival OS safety including long term toxicity
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None